Publications by authors named "X S Davis"

Treatment with the toll-like receptor (TLR) 4 agonist monophosphoryl lipid A (MPLA) conditions innate immunocytes to respond robustly to subsequent infection, a phenotype termed innate immune memory. Our published studies show that metabolic reprogramming of macrophages is a prominent feature of the memory phenotype. We undertook studies to define the functional contributions of tricarboxylic acid (TCA) cycle reprogramming to innate immune memory.

View Article and Find Full Text PDF

Different stimuli can induce innate immune memory to improve pathogen defense or worsen cardiometabolic disease. However, it is less clear if the same stimuli can induce both the protective and detrimental effects of innate immune memory. We previously showed that weight loss induces innate immune memory in adipose macrophages that correlates with worsened diabetes risk after weight regain.

View Article and Find Full Text PDF

Purpose: Patient education is a core component of treating fibromyalgia and central sensitization disorders. We sought to evaluate whether patients with fibromyalgia prefer virtual or in-person educational classes as part of their treatment program, identify underlying factors with their educational modality choice, and highlight benefits or barriers associated with in-person or online educational sessions.

Design: A cross-sectional survey with a qualitative feedback component was utilized.

View Article and Find Full Text PDF
Article Synopsis
  • The August 2023 article in Science Signaling critiques the traditional macrophage classifications (M1/M2) by showing how transforming growth factor β (TGF-β) alters macrophage metabolism and function, leading to an unexpected phenotype.
  • TGF-β-treated macrophages increase glycolysis, decrease pro-inflammatory cytokines, and elevate coagulation factors, indicating a complex role in inflammation and metabolism during conditions like sepsis.
  • The study connects TGF-β's effects to COVID-19, showing similar metabolic changes in macrophages and suggesting that targeting TGF-β could be a therapeutic strategy for diseases characterized by uncontrolled inflammation and coagulation issues.
View Article and Find Full Text PDF